AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN

Defense DEF

TRICARE rules affecting beneficiary access to clinical laboratory services. H.R. 4435, the Howard P. "Buck" McKeon National Defense Authorization Act for FY 2015. S. 2410, the Carl Levin National Defense Authorization Act for FY 2015.

Contacted: Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; White House Office; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); SENATE; Defense, Dept of (DOD)

Bills named: S. 2410 (113th), H.R. 4435 (113th)

Health Issues HCR

Reimbursement and coverage issues related to the Medicare Clinical Laboratory Fee Schedule and the Physician Fee Schedule, including implementation of the Protecting Access to Medicare Act of 2014(P.L. 113-93), misvalued codes, and pricing for molecular diagnostic tests by CMS. Proposed FDA regulation of laboratory-developed tests. Narrowing the In-Office Ancillary Services Exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy services, H.R. 2914, the Promoting Integrity in Medicare Act of 2013. 21st Century Cures Initiative.

Contacted: Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); SENATE; Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); White House Office

Bills named: H.R. 2914 (113th)

Medicare/Medicaid MMM

Reimbursement and coverage issues related to the Medicare Clinical Laboratory Fee Schedule and the Physician Fee Schedule, including implementation of the Protecting Access to Medicare Act of 2014(P.L. 113-93), misvalued codes, and pricing for molecular diagnostic tests by CMS. Proposed FDA regulation of laboratory-developed tests. Narrowing the In-Office Ancillary Services Exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy services, H.R. 2914, the Promoting Integrity in Medicare Act of 2013. 21st Century Cures Initiative.

Contacted: Office of Management & Budget (OMB); White House Office; SENATE; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2914 (113th)

Budget/Appropriations BUD

Reimbursement and coverage issues related to the Medicare Clinical Laboratory Fee Schedule and the Physician Fee Schedule, including implementation of the Protecting Access to Medicare Act of 2014(P.L. 113-93), misvalued codes, and pricing for molecular diagnostic tests by CMS. Proposed FDA regulation of laboratory-developed tests. Narrowing the In-Office Ancillary Services Exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy services, H.R. 2914, the Promoting Integrity in Medicare Act of 2013. 21st Century Cures Initiative.

Contacted: Food & Drug Administration (FDA); Defense, Dept of (DOD); SENATE; White House Office; Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2914 (113th)

Medical/Disease Research/Clinical Labs MED

Reimbursement and coverage issues related to the Medicare Clinical Laboratory Fee Schedule and the Physician Fee Schedule, including implementation of the Protecting Access to Medicare Act of 2014(P.L. 113-93), misvalued codes, and pricing for molecular diagnostic tests by CMS. Proposed FDA regulation of laboratory-developed tests. Narrowing the In-Office Ancillary Services Exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy services, H.R. 2914, the Promoting Integrity in Medicare Act of 2013. 21st Century Cures Initiative.

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Congressional Budget Office (CBO); Defense, Dept of (DOD); White House Office; Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB)

Bills named: H.R. 2914 (113th)